Outcomes | Number of studies | OR/WMD (95%CI) | P | I2 (%) |
---|---|---|---|---|
Premature delivery [3, 4, 6, 9, 10, 20, 21, 26, 28,29,30, 32, 35, 36, 42,43,44,45,46, 48,49,50] | 22 | 1.57 (1.00, 2.48) | 0.052 | 98.8 |
6 | 1.55 (1.17, 2.06) | 0.003 | 0.0 | |
13 | 1.48 (1.25, 1.75) | < 0.001 | 85.4 | |
Region | ||||
 Europe |  | 1.55 (1.15, 2.09) | 0.004 | 53.9 |
 North America |  | 1.46 (1.12, 1.89) | 0.005 | 89.5 |
 Asia |  | 1.42 (1.01, 2.00) | 0.047 | 89.7 |
7 | -135.10 (-244.27, -25.94) | 0.015 | 97.7 | |
Study design | ||||
 Cohort study |  | -173.78 (-295.12, -52.43) | 0.005 | 98.2 |
 Case-control study |  | -23.25 (-330.96, 284.47) | 0.882 | 92.6 |
Region | ||||
 Europe |  | -71.64 (-146.99, 3.72) | 0.062 | 82.9 |
 North America |  | -162.00 (-235.49, -88.51) | < 0.001 | 78.6 |
 Asia |  | -342.59 (-362.97, -322.22) | < 0.001 | NA |
12 | 1.73 (1.46, 2.06) | < 0.001 | 65.8 | |
Study design | ||||
 Cohort study |  | 1.75 (1.46, 2.09) | < 0.001 | 72.2 |
 Case-control study |  | 1.16 (0.29, 4.57) | 0.833 | 66.4 |
 Cross-sectional study |  | 1.99 (0.72, 5.51) | 0.183 | NA |
Region | ||||
 Europe |  | 1.41 (0.87, 2.28) | 0.161 | 33.0 |
 North America |  | 1.80 (1.45, 2.25) | < 0.001 | 52.8 |
 Asia |  | 1.72 (1.19, 2.49) | 0.004 | 84.8 |
 Africa |  | 1.99 (0.72, 5.51) | 0.183 | NA |
3 | 1.05 (0.71, 1.54) | 0.818 | 63.2 | |
4 | 1.93 (0.82, 4.56) | 0.133 | 56.0 | |
3 | 1.41 (0.76, 2.61) | 0.278 | 0.0 | |
Congenital abnormalities [3, 4, 9, 18, 21, 26, 29, 35, 45,46,47,48,49,50] | 12 | 1.24 (1.13, 1.37) | < 0.001 | 42.3 |
2 | 1.70 (1.41, 2.06) | < 0.001 | 36.8 | |
2 | 1.23 (1.16, 1.30) | < 0.001 | 0.0 |